Raymond James Upgrades Neogenomics (NEO) to Outperform
Tweet Send to a Friend
Raymond James analyst Andrew Cooper upgraded Neogenomics (NASDAQ: NEO) from Market Perform to Outperform with a price target of $53.00.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE